ROCK-IN-D3 | CAS#1219727-16-8 | ROCK inhibitor

MedKoo Cat#: 562376 | Name: ROCK-IN-D3

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ROCK-IN-D3 is a potent and selective ROCK inhibitor.

Chemical Structure

ROCK-IN-D3

CAS#1219727-16-8

Theoretical Analysis

MedKoo Cat#: 562376

Name: ROCK-IN-D3

CAS#: 1219727-16-8

Chemical Formula: C20H22N4O

Exact Mass: 334.1794

Molecular Weight: 334.42

Elemental Analysis: C, 71.83; H, 6.63; N, 16.75; O, 4.78

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

ROCK-IN-D3; ROCK IN D3; ROCKIND3; ROCK inhibitor D3; ROCK-inhibitor-D3;

IUPAC/Chemical Name

1-Benzyl-1-isopropyl-3-[4-(1H-pyrazol-4-yl)-phenyl]-urea

InChi Key

LFGPPSFNJYTRRE-UHFFFAOYSA-N

InChi Code

InChI=1S/C20H22N4O/c1-15(2)24(14-16-6-4-3-5-7-16)20(25)23-19-10-8-17(9-11-19)18-12-21-22-13-18/h3-13,15H,14H2,1-2H3,(H,21,22)(H,23,25)

SMILES Code

O=C(NC1=CC=C(C2=CNN=C2)C=C1)N(CC3=CC=CC=C3)C(C)C

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 334.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Rasche L, Chavan SS, Stephens OW, Patel PH, Tytarenko R, Ashby C, Bauer M, Stein C, Deshpande S, Wardell C, Buzder T, Molnar G, Zangari M, van Rhee F, Thanendrarajan S, Schinke C, Epstein J, Davies FE, Walker BA, Meissner T, Barlogie B, Morgan GJ, Weinhold N. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun. 2017 Aug 16;8(1):268. doi: 10.1038/s41467-017-00296-y. PubMed PMID: 28814763; PubMed Central PMCID: PMC5559527. 2: Liu K, Sun Y, Liu D, Ye S. Inhibition of Wnt/β-catenin signaling by IWR1 induces expression of Foxd3 to promote mouse epiblast stem cell self-renewal. Biochem Biophys Res Commun. 2017 Aug 26;490(3):616-622. doi: 10.1016/j.bbrc.2017.06.086. Epub 2017 Jun 16. PubMed PMID: 28630002. 3: Chen Y, Huang W, Jiang W, Wu X, Ye B, Zhou X. HIV-1 Tat Regulates Occludin and Aβ Transfer Receptor Expression in Brain Endothelial Cells via Rho/ROCK Signaling Pathway. Oxid Med Cell Longev. 2016;2016:4196572. doi: 10.1155/2016/4196572. Epub 2016 Aug 2. PubMed PMID: 27563375; PubMed Central PMCID: PMC4985576. 4: Paintlia AS, Paintlia MK, Hollis BW, Singh AK, Singh I. Interference with RhoA-ROCK signaling mechanism in autoreactive CD4+ T cells enhances the bioavailability of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis. Am J Pathol. 2012 Sep;181(3):993-1006. doi: 10.1016/j.ajpath.2012.05.028. Epub 2012 Jul 13. PubMed PMID: 22796435; PubMed Central PMCID: PMC3432427. 5: Uranbileg B, Yamamoto H, Park JH, Mohanty AR, Arakawa-Takeuchi S, Jinno S, Okayama H. Cdc6 protein activates p27KIP1-bound Cdk2 protein only after the bound p27 protein undergoes C-terminal phosphorylation. J Biol Chem. 2012 Feb 24;287(9):6275-83. doi: 10.1074/jbc.M111.318295. Epub 2012 Jan 5. PubMed PMID: 22223646; PubMed Central PMCID: PMC3307327. 6: Zhong WB, Hsu SP, Ho PY, Liang YC, Chang TC, Lee WS. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway. Biochem Pharmacol. 2011 Dec 1;82(11):1663-72. doi: 10.1016/j.bcp.2011.08.021. Epub 2011 Sep 2. PubMed PMID: 21907187. 7: Ordóñez-Morán P, Alvarez-Díaz S, Valle N, Larriba MJ, Bonilla F, Muñoz A. The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):355-61. doi: 10.1016/j.jsbmb.2010.02.031. Epub 2010 Mar 17. PubMed PMID: 20223287. 8: Chen J, Guerriero E, Lathrop K, SundarRaj N. Rho/ROCK signaling in regulation of corneal epithelial cell cycle progression. Invest Ophthalmol Vis Sci. 2008 Jan;49(1):175-83. doi: 10.1167/iovs.07-0488. PubMed PMID: 18172090. 9: Shankar K, Liu X, Singhal R, Chen JR, Nagarajan S, Badger TM, Ronis MJ. Chronic ethanol consumption leads to disruption of vitamin D3 homeostasis associated with induction of renal 1,25 dihydroxyvitamin D3-24-hydroxylase (CYP24A1). Endocrinology. 2008 Apr;149(4):1748-56. Epub 2007 Dec 27. PubMed PMID: 18162528; PubMed Central PMCID: PMC2276718. 10: Vertino AM, Bula CM, Chen JR, Almeida M, Han L, Bellido T, Kousteni S, Norman AW, Manolagas SC. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. J Biol Chem. 2005 Apr 8;280(14):14130-7. Epub 2005 Jan 25. PubMed PMID: 15671029. 11: Zhao Z, Rivkees SA. Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation. Dev Dyn. 2003 Jan;226(1):24-32. PubMed PMID: 12508221.